On Air Now

Upcoming Shows

Program Schedule »

Listen

Listen Live Now » 1450 AM Holland, MI

Weather

Current Conditions(Holland,MI 49422)

More Weather »
52° Feels Like: 52°
Wind: ENE 0 mph Past 24 hrs - Precip: 0”
Current Radar for Zip

Tonight

Clear 47°

Tomorrow

Mostly Sunny 67°

Fri Night

Mostly Clear 47°

Alerts

Cavaliers' Varejao to miss rest of season with blood clot

Cleveland Cavaliers Anderson Varejao talks with a TV reporter during the second quarter of the team's NBA basketball game against the Detroi
Cleveland Cavaliers Anderson Varejao talks with a TV reporter during the second quarter of the team's NBA basketball game against the Detroi

(Reuters) - Cleveland Cavaliers forward Anderson Varejao will miss the rest of the National Basketball Association (NBA) season undergoing treatment for a blood clot in his right lung, the team said on Monday.

The 30-year-old Brazilian, who was the NBA's top rebounder until a knee injury requiring surgery sidelined him in December, was admitted to the Cleveland Clinic last Thursday where he is being treated with blood thinners.

He will need to remain on blood thinning medication for approximately three months but is expected to make a full recovery, according to the Cavaliers.

"Clearly our players' health is our top concern and we are disappointed for Anderson, and his family," Cavaliers General Manager Chris Grant said in a statement.

"We know what a competitor he is and how much he wants to be on the court helping his teammates. In the meantime, he has our full support and we look forward to welcoming him back as he recovers."

Taken in the second round of the 2004 NBA Draft, Varejao was traded to the Cavaliers that same year and has spent his entire career in Cleveland.

Varejao, who has not played since suffering his knee injury, was averaging a career-high 14.1 points and a team-leading 14.4 rebounds in 25 games for a Cavaliers team that is 14th in the 15-team Eastern Conference with 40 games left in the season.

(Reporting by Steve Keating in Toronto; Editing by Frank Pingue)

Comments